Caribou Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Caribou Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q3 2024.
  • Caribou Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $20.5M, a 9.64% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $20.5M -$2.19M -9.64% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $21.1M -$2.07M -8.93% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $21.7M -$2.06M -8.67% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $22.2M -$2.05M -8.45% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $22.7M -$1.95M -7.9% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $23.2M -$2.04M -8.1% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $23.7M -$2.03M -7.9% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $24.2M +$24.2M Dec 31, 2022 10-K 2024-03-11
Q3 2022 $24.6M Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $25.3M Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $25.7M Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.